PAPASH Syndrome with a Pathogenic PSTPIP1 p.(Ala230Thr) Variant: A Case Report of Therapeutic Complexity

Authors

  • Meri Tikka Dermatology Department, Mikkeli Central Hospital, Mikkeli, Finland
  • Tiina Ilves Dermatology Department, Mikkeli Central Hospital, Mikkeli, Finland

DOI:

https://doi.org/10.2340/actadv.v105.43622

Keywords:

PAPASH syndrome, autoinflammatory syndrome, PSTPIP1, p.(Ala230Thr), PAPASH Syndrome, Syndromic Hidradenitis Suppurativa

Downloads

Download data is not yet available.

References

Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol 2013; 149: 762–764. DOI: https://doi.org/10.1001/jamadermatol.2013.2907

Maronese CA, Moltrasio C, Marzano AV. Hidradenitis suppurativa-related autoinflammatory syndromes: an updated review on the clinics, genetics, and treatment of pyoderma gangrenosum, acne and suppurative hidradenitis (PASH), pyogenic arthritis, pyoderma gangrenosum, acne and suppurative hidradenitis (PAPASH), synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO), and rarer forms. Dermatol Clin 2024; 42: 247–265. DOI: https://doi.org/10.1016/j.det.2023.12.004

Garzorz N, Papanagiotou V, Atenhan A, Andres C, Eyerich S, Eyerich K, et al. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? J Eur Acad Dermatol Venereol 2016; 30: 141–143. DOI: https://doi.org/10.1111/jdv.12631

Nikolakis G, Kreibich K, Vaiopoulos A, Kaleta K, Talas J, Becker M, et al. Case report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab. F1000Res 2021; 10: 381. DOI: https://doi.org/10.12688/f1000research.52100.1

Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: the autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol 2021; 39: 240–247. DOI: https://doi.org/10.1016/j.clindermatol.2020.10.016

Satoh TK. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: insights into pathogenic mechanisms and shared pathways. J Dermatol 2024; 51: 160–171. DOI: https://doi.org/10.1111/1346-8138.17028

Boursier G, Piram M, Rittore C, Sarrabay G, Touitou I. Phenotypic associations of PSTPIP1 sequence variants in PSTPIP1-associated autoinflammatory diseases. J Invest Dermatol 2021; 141: 1141–1147. DOI: https://doi.org/10.1016/j.jid.2020.08.028

Maitrepierre F, Marzano AV, Lipsker D. A Unified concept of acne in the PAPA spectrum disorders. Dermatology 2021; 237: 827–834. DOI: https://doi.org/10.1159/000509874

Cugno M, Borghi A, Marzano AV. PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment. Am J Clin Dermatol 2017; 18: 555–562. DOI: https://doi.org/10.1007/s40257-017-0265-1

Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 2017; 176: 1588–1598. DOI: https://doi.org/10.1111/bjd.15226

Nikolakis G, Kaleta K, Vaiopoulos A, Wolter K, Baroud S, Wojas-Pelc A, et al. Phenotypes and pathophysiology of syndromic hidradenitis suppurativa: different faces of the same disease? A systematic review. Dermatology 2021; 237: 673–697. DOI: https://doi.org/10.1159/000509873

Marzano AV, Genovese G, Moltrasio C, Tricarico PM, Gratton R, Piaserico S, et al. Whole-exome -sequencing in 10 unrelated patients with syndromic hidradenitis suppurativa: a preliminary step for a genotype-phenotype correlation. Dermatology 2022; 238: 860–869. DOI: https://doi.org/10.1159/000521263

Published

2025-08-18

How to Cite

Tikka, M., & Ilves, T. (2025). PAPASH Syndrome with a Pathogenic PSTPIP1 p.(Ala230Thr) Variant: A Case Report of Therapeutic Complexity. Acta Dermato-Venereologica, 105, adv43622. https://doi.org/10.2340/actadv.v105.43622